2026 Scientific Sessions

From Symptoms to Solutions: Strategic Timing in Tricuspid Regurgitation Management

This session explores the evolving strategies for managing tricuspid regurgitation (TR), emphasizing patient selection, medical optimization, imaging, and procedural timing. Through expert presentations, case debates, and a town hall discussion, attendees will gain practical insights into tailoring TR interventions for optimal outcomes.
Introductory Remarks
The Art and Science of Patient Selection
Anita W. Asgar, M.D., FSCAI, Northwestern University Feinberg School of Medicine, Chicago, IL
Optimizing Outcomes in Tricuspid Regurgitation: The Role of Medication and Pre-habilitation
Molly Szerlip, M.D., FSCAI, Baylor Scott & White The Heart Hospital - Plano, Richardson, TX
Imaging the Tricuspid Valve: A Multi Modal Approach to Transcatheter Planning
Omar Khalique, M.D., FSCAI, St. Francis Hospital & Heart Center, Closter, NJ
Discussion
Case Introduction: Patient with Severe TR
Gagan Singh, M.D., FSCAI, UC Davis Medical Center, Sacramento, CA
TTVR is the Right Option for this Patient
David J. Cohen, M.D., FSCAI, St. Francis Hospital, New York, NY
T-TEER is the Right Option for this Patient
Paul Dennis Mahoney, M.D., FSCAI, ECU Health Medical Center, Greenville, NC
Case Conclusion & Discussion
Gagan Singh, M.D., FSCAI, UC Davis Medical Center, Sacramento, CA
Town Hall: Are Symptoms Worth the Money Without Hard Outcomes?
Michael J. Rinaldi, M.D., FSCAI, Sanger Heart & Vascular Institute, Charlotte, NC